Gene · 6508
Papers3,779
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,779
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis. | Bladder Cancer | 2019 | 36157135 | PubTator, text mining | PubMed |
| Adrenal metastasis of anaplastic meningioma: report of a rare case. | Folia Neuropathol | 2019 | 32337950 | PubTator, text mining | PubMed |
| The Role of a Minimum Immunohistochemical Antibody Panel in Confirming Undifferentiated Nasopharyngeal Carcinoma: A Cross-Sectional Study at the Muhimbili National Hospital, Dar-es-Salaam, Tanzania. | Niger Med J | 2019 | 32180656 | PubTator, text mining | PubMed |
| Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the BCOR-CCNB3- & CIC-DUX4-positive sarcomas. | Indian J Med Res | 2019 | 32048619 | PubTator, text mining | PubMed |
| Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis. | Front Genet | 2019 | 32010184 | PubTator, text mining | PubMed |
| Role of NKCC1 and KCC2 in Epilepsy: From Expression to Function. | Front Neurol | 2019 | 32010056 | PubTator, text mining | PubMed |
| The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment. | Contemp Oncol (Pozn) | 2019 | 31992952 | PubTator, text mining | PubMed |
| Eosinophilic cytoplasmic inclusions in type 2 papillary renal cell carcinoma. | Pathologica | 2019 | 31965115 | PubTator, text mining | PubMed |
| Malignant gastrointestinal neuroectodermal tumor, presenting as a second malignancy after gastric adenocarcinoma: a case report and literature review. | J Gastrointest Oncol | 2019 | 31949932 | PubTator, text mining | PubMed |
| A Practical Approach to the Differential Diagnosis of Intracranial Tumors: Gross, Histology, and Immunoprofile-based Algorithm. | Cureus | 2019 | 31938662 | PubTator, text mining | PubMed |
| Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study. | Cureus | 2019 | 31938642 | PubTator, text mining | PubMed |
| Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China. | Int J Clin Exp Pathol | 2019 | 31933740 | PubTator, text mining | PubMed |
| Immunohistochemical evaluation of tumor budding in colorectal cancer: an important parameter with prognostic value. | Rom J Morphol Embryol | 2019 | 31912094 | PubTator, text mining | PubMed |
| Unusual Presentation of a Rare Tumor: Histiocytic Sarcoma Presenting as a Finger Growth. | Cureus | 2019 | 31890359 | PubTator, text mining | PubMed |
| Tumor Budding Detection System in Whole Slide Pathology Images. | J Med Syst | 2019 | 31853654 | PubTator, text mining | PubMed |
| Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report. | J Med Case Rep | 2019 | 31852518 | PubTator, text mining | PubMed |
| Polyoxidonium® Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer. | Front Immunol | 2019 | 31849934 | PubTator, text mining | PubMed |
| Low-Grade Chondrosarcoma In The Sellar Area: Case Report And Literature Review. | Onco Targets Ther | 2019 | 31849484 | PubTator, text mining | PubMed |
| Cytotoxicity and effect on wound re-epithelialization after topical administration of tranexamic acid. | BJS Open | 2019 | 31832591 | PubTator, text mining | PubMed |
| Pure squamous cell carcinoma of the gallbladder locally invading the liver and abdominal cavity: A case report and review of the literature. | World J Clin Cases | 2019 | 31832423 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6508/papers?page=57